← Browse by Condition
Medical Condition

myocardial infarction

Total Trials
15
Recruiting Now
15
Trial Phases
Phase 3, Phase 4

ClinicalMetric tracks all active clinical trials for myocardial infarction sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — myocardial infarction Clinical Trials

How many clinical trials are currently recruiting for myocardial infarction?
ClinicalMetric currently tracks 15 actively recruiting clinical trials for myocardial infarction, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 15. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for myocardial infarction?
myocardial infarction research spans Phase 3 (2 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a myocardial infarction clinical trial?
Eligibility criteria for myocardial infarction trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
2
Phase 4
1
Top Sponsors
Queen Mary University of London 2 trials
Ottawa Heart Institute Research Corporation 1 trial
Peerbridge Health, Inc 1 trial
ROM Technologies, INC 1 trial
Xi'an International Medical Center Hospital 1 trial

Recruiting Clinical Trials

NCT06174753 Phase 3
Recruiting
Dapagliflozin in STEMI
Enrollment
256 pts
Location
Canada
Sponsor
Ottawa Heart Institute Researc...
View Trial →
NCT06699056
Recruiting
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Enrollment
2,000 pts
Location
United States
Sponsor
Peerbridge Health, Inc
View Trial →
NCT06040528
Recruiting
Early Discharge Pathway Registry
Enrollment
20,000 pts
Location
United Kingdom
Sponsor
Queen Mary University of Londo...
View Trial →
NCT05255705
Recruiting
Barts Revascularisation Registry
Enrollment
20,000 pts
Location
United Kingdom
Sponsor
Queen Mary University of Londo...
View Trial →
NCT05972070
Recruiting
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
Enrollment
500 pts
Location
United States
Sponsor
ROM Technologies, INC
View Trial →
NCT06857838
Recruiting
Myocardialbridge Bypass Graft Surgery Efficacy Verification
Enrollment
500 pts
Location
China
Sponsor
Xi'an International Medical Ce...
View Trial →
NCT06343844
Recruiting
Disparities in Myocardial Infarction Remodeling According to Gender
Enrollment
1,650 pts
Location
France
Sponsor
University Hospital, Angers
View Trial →
NCT04499859 Phase 4
Recruiting
Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI
Enrollment
3,548 pts
Location
South Korea
Sponsor
Kiyuk Chang, MD,PhD
View Trial →
NCT07636642
Recruiting
Sixth Generation High-sensitivity Cardiac Troponin T for the Early Rule Out of Myocardial Infarction: a Controlled Before and After Study
Enrollment
19,500 pts
Location
United Kingdom
Sponsor
University of Edinburgh
View Trial →
NCT07301034 Phase 3
Recruiting
A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack
Enrollment
332 pts
Location
Austria, Denmark, It...
Sponsor
Novo Nordisk A/S
View Trial →
NCT05699629
Recruiting
Prospective Coronary Heart Disease Cohort
Enrollment
50,000 pts
Location
China
Sponsor
Shandong First Medical Univers...
View Trial →
NCT04521699
Recruiting
Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk.
Enrollment
100 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT05920629
Recruiting
Moderate Alcohol Consumption and Heart Function in Patients With a Recent Myocardial Infarction
Enrollment
220 pts
Location
Switzerland
Sponsor
Baris Gencer
View Trial →
NCT07142265
Recruiting
Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients
Enrollment
300 pts
Location
Russia
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06271577
Recruiting
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
Enrollment
1,000 pts
Location
United States, Unite...
Sponsor
AliveCor
View Trial →

Related Conditions

heart failure (3) st elevation myocardial infarction (2) stable angina (2) myocardial ischemia (2) ventricular ejection fraction (1) lvf (1) lv dysfunction (1) atrial enlargement (1) conduction defect (1) valvular heart disease (1) ischemic heart disease (1) cardiotoxicity (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology